Update 2021: Pulmonale Folgen nach COVID-19-Pneumonie

Eine akute COVID-19-Pneumonie kann zu anhaltenden Veränderungen der Lunge mit unterschiedlichen bildgebenden und histopathologischen Mustern führen. Darüber hinaus ist eine SARS-CoV-2-Infektion mit einem erhöhten Risiko für pulmonal-vaskuläre Endothelialitis und Thrombose verbunden. Basierend auf einer selektiven Literaturrecherche werden in dieser Übersicht aktuelle Erkenntnisse zu pulmonalen Folgen von COVID-19 mit Implikationen für das klinische Management zusammengefasst.

Abstract

Acute COVID-19 pneumonia may result in persistent changes with various imaging and histopathological patterns, including organizing pneumonia and pulmonary fibrosis. In addition, SARS-CoV-2 infection is associated with increased risk of pulmonary vascular endothelialitis and thrombosis. Herein, current findings on pulmonary consequences of COVID-19 with implications for clinical management are summarized based on a selective literature review.

Schlüsselwörter

Post-COVID - Lungenfibrose - organisierende Pneumonie

Key words

post-COVID - pulmonary fibrosis - organizing pneumonia

Publication History

Article published online:
13 July 2021

• Literatur

• 1 Kluge S, Janssens U, Spinner CD. et al. Clinical Practice Guideline: Recommendations on Inpatient Treatment of Patients with COVID-19. Deutsches Arzteblatt international 2021; 118
• 2 Leo F, Wormanns D, Grohé C. [COVID-19: A Pneumological Point of View – Long-Term Sequelae of COVID-19 – Implications For Follow-up In Respiratory Medicine]. Deutsche medizinische Wochenschrift (1946) 2020; 145: 1086-1092
• 3 Dhawan RT, Gopalan D, Howard L. et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. The Lancet Respiratory Medicine 2021; 9: 107-116
• 4 Vadász I, Husain-Syed F, Dorfmüller P. et al Severe organising pneumonia following COVID-19. Thorax 2020; (online ahead of print)
• 5 Wang Y, Jin C, Wu CC. et al. Organizing pneumonia of COVID-19: Time-dependent evolution and outcome in CT findings. PloS one 2020; 15: e0240347
• 6 Myall KJ, Mukherjee B, Castanheira AM. et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Annals of the American Thoracic Society 2021; 18: 799-806
• 7 van Gassel RJJ, Bels JLM, Raafs A. et al. High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19. American journal of respiratory and critical care medicine 2021; 203: 371-374
• 8 Sonnweber T, Sahanic S, Pizzini A. et al Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. The European respiratory journal 2021; 57 (online ahead of print)
• 9 Huang C, Huang L, Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England) 2021; 397: 220-232
• 10 Han X, Fan Y, Alwalid O. et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology 2021; 299: E177-E186
• 11 Wu X, Liu X, Zhou Y. et al 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. The Lancet Respiratory medicine 2021; (online ahead of print)
• 12 Remy-Jardin M, Duthoit L, Perez T. et al. Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: Dual-energy CT (DECT) angiographic study in 55 patients. EClinicalMedicine 2021; 34: 100778